These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9577121)
41. [Insufficient evidence for oral glucocorticoids as first-line therapy for acute gout]. Jacobs JW; Bijlsma JW Ned Tijdschr Geneeskd; 2009; 153():A615. PubMed ID: 19785794 [TBL] [Abstract][Full Text] [Related]
42. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834 [TBL] [Abstract][Full Text] [Related]
43. Colchicine--what is its place in the management of acute gout? Winzenberg T; Zochling J Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668 [TBL] [Abstract][Full Text] [Related]
44. An unusual presentation of polyarticular tophaceous gout. Khanna D; Shrivastava A Rheumatology (Oxford); 2006 Sep; 45(9):1095. PubMed ID: 16943372 [No Abstract] [Full Text] [Related]
48. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738 [TBL] [Abstract][Full Text] [Related]
50. Opportunities for improving medication use and monitoring in gout. Singh JA; Hodges JS; Asch SM Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554 [TBL] [Abstract][Full Text] [Related]
52. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
54. Discussion following cases 4 and 5. Croft JD Am J Med; 2006 Nov; 119(11 Suppl 1):S16-9. PubMed ID: 17059906 [No Abstract] [Full Text] [Related]
55. Allopurinol use and prevention of gout attack. Lai SW; Kuo YH; Liao KF Eur J Clin Pharmacol; 2021 Jan; 77(1):145. PubMed ID: 32803286 [No Abstract] [Full Text] [Related]
56. Gout in Aotearoa New Zealand: the equity crisis continues in plain sight. Dalbeth N; Dowell T; Gerard C; Gow P; Jackson G; Shuker C; Te Karu L N Z Med J; 2018 Nov; 131(1485):8-12. PubMed ID: 30408813 [No Abstract] [Full Text] [Related]
57. [The use of acupuncture reflexotherapy in the combined treatment of patients with chronic gouty polyarthritis]. Zherebkin VV Lik Sprava; 1998; (2):151-3. PubMed ID: 9670693 [TBL] [Abstract][Full Text] [Related]
58. Summaries for Patients. Oral Prednisolone in the Treatment of Acute Gout. Ann Intern Med; 2016 Apr; 164(7):. PubMed ID: 26902107 [No Abstract] [Full Text] [Related]
59. [Action of a uricemic depressor (allopurinol) co-administered with a diuretic (chlorthalidon) to gout patients]. Chegoriansky J; Piterbarg R; Catoggio PM Prensa Med Argent; 1967 Apr; 54(9):429-32. PubMed ID: 5602628 [No Abstract] [Full Text] [Related]